Full video transcriptClick to expand
Auto-generated transcript of @braecarlton's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00My testosterone experience stays zero. Hi, my name is Bray and I'm a 34 year old cisgendered
- 0:07male and I have low testosterone. Why do I have low testosterone? There might be a lot of reasons,
- 0:13but I am on a medication that actually lowers testosterone. I got two lab tests done both in the
- 0:20morning and my levels were in like the 70s and like the bottom is like 150s so it's pretty darn low.
- 0:27This is all pretty new to me but I've looked at the symptoms of low testosterone,
- 0:32depression, lack of concentration, low muscle mass, low libido, I have all of the symptoms and I have
- 0:40for a long time now. Today my doctor prescribed me vogelsco. I don't know how to say it. That's how
- 0:46it's spelled 50 milligrams per day and I get to pick it up from the pharmacy tomorrow. I'm very
- 0:53excited about this process and so I'm starting this series hopefully to track changes and
- 0:59track benefits and hopefully it turns out great. It's exciting. If you have any questions or if
- 1:06you want to follow along make sure you like, follow and comment and I'll see you all tomorrow.
TRT Day 0 claims: what the science says before you start
Quick answer
The creator presents with medication-induced secondary hypogonadism, reporting total testosterone levels in the 70s ng/dL on two separate morning draws, which is severely below the clinical threshold of 300 ng/dL used by the Endocrine Society and AUA for diagnosing hypogonadism. He has been prescribed Vogelxo (testosterone gel 1.62%) at 50 mg/day, a labeled starting dose for this FDA-approved topical androgen product. The underlying medication causing suppression is not named, which matters clinically because addressing the root cause or switching medications may be relevant to long-term management.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT Day 0 claims: what the science says before you start, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT Day 0 claims: what the science says before you start is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT Day 0 claims: what the science says before you start" from Brae👾. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator presents with medication-induced secondary hypogonadism, reporting total testosterone levels in the 70s ng/dL on two separate morning draws, which is severely below the clinical threshold of 300 ng/dL used by the Endocrine Society and AUA for diagnosing hypogonadism.
The reason this review is not generic is the source wording and the canonical claim label "trt my trt experience day 0 trtjourney testosteronetherapy lowtr." In this clip, the useful excerpt is: "My testosterone experience stays zero." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator presents with medication-induced secondary hypogonadism, reporting total testosterone levels in the 70s ng/dL on two separate morning draws, which is severely below the clinical threshold of 300 ng/dL used by the Endocrine Society and AUA for diagnosing hypogonadism.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator presents with medication-induced secondary hypogonadism, reporting total testosterone levels in the 70s ng/dL on two separate morning draws, which is severely below the clinical threshold of 300 ng/dL used by the Endocrine Society and AUA for diagnosing hypogonadism. He has been prescribed Vogelxo (testosterone gel 1.62%) at 50 mg/day, a labeled starting dose for this FDA-approved topical androgen product. The underlying medication causing suppression is not named, which matters clinically because addressing the root cause or switching medications may be relevant to long-term management.
- The Endocrine Society defines hypogonadism as total testosterone below 300 ng/dL confirmed on two separate morning draws. Levels in the 70s ng/dL are severely deficient by any major guideline.
- Two morning testosterone tests before diagnosis is the correct clinical protocol per Bhasin et al., 2018, JCEM. Many people skip this step. The creator did not.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Endocrine Society defines hypogonadism as total testosterone below 300 ng/dL confirmed on two separate morning draws. Levels in the 70s ng/dL are severely deficient by any major guideline.
- Two morning testosterone tests before diagnosis is the correct clinical protocol per Bhasin et al., 2018, JCEM. Many people skip this step. The creator did not.
- Multiple medication classes, including opioids and certain antidepressants, are documented causes of drug-induced secondary hypogonadism (Rajagopal et al., 2004, Journal of Pain and Symptom Management).
- Vogelxo is a brand-name testosterone gel regulated as an FDA-approved drug. It is not equivalent to compounded testosterone gels, which are prepared under a different regulatory framework.
- Testosterone gels carry an FDA-documented transfer risk to partners and children if skin-to-skin contact occurs before the product fully dries.
- TRT in a 34-year-old man raises fertility considerations. Exogenous testosterone suppresses LH and FSH, which can reduce sperm production. This warrants discussion with a urologist or reproductive endocrinologist before starting.
- Symptoms like depression and poor concentration have multiple potential causes. Low testosterone may contribute, but attributing all symptoms to a single hormonal cause before treatment is a working hypothesis, not a confirmed diagnosis.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @braecarlton actually say?
Bray is a 34-year-old man who says he has low testosterone caused, at least in part, by another medication he is already taking. He got two morning blood draws and says both came back "in the 70s" nanograms per deciliter, well below what he describes as a floor of "like the 150s." His doctor prescribed Vogelxo, a brand-name testosterone gel, at 50 milligrams per day. He says he has been experiencing depression, poor concentration, low muscle mass, and low libido, and attributes all of them to low testosterone. He is starting a video series to document the process.
That is a pretty clean, specific setup for a first video. No wild claims, no miracle framing. He is not selling anything here. He just spelled the drug name wrong in the caption, which is forgivable.
Does the science back this up?
Mostly, yes. Total testosterone below 300 ng/dL is the threshold most major guidelines use to define hypogonadism, and levels in the 70s are genuinely, clinically low. The symptoms he listed are textbook secondary effects of androgen deficiency.
The American Urological Association's 2018 guidelines and the Endocrine Society's 2018 clinical practice guideline (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) both require at least two early-morning testosterone measurements before diagnosis, which he says he got. That is actually more rigorous than a lot of people bother with. The 50 mg/day starting dose for Vogelxo aligns with the labeled prescribing information for that product, though dose adjustments are standard practice and this should not be read as a recommendation.
His claim that "a medication" is suppressing his testosterone is plausible and well-documented. Opioids, corticosteroids, and antidepressants, among others, are all known to suppress the hypothalamic-pituitary-gonadal axis (Rajagopal et al., 2004, Journal of Pain and Symptom Management).
What did they get right or wrong?
More right than wrong, which is not something you say often about TRT content on TikTok.
He got the diagnostic process right. Two morning labs is the correct methodology. He correctly identified that his levels were far below normal range. His symptom list, "depression, lack of concentration, low muscle mass, low libido," directly matches the clinical presentation described in hypogonadism literature (Zitzmann, 2009, Nature Reviews Urology).
The one area worth flagging is attribution. He says he has had these symptoms "for a long time" and appears to connect them entirely to low testosterone. That may be accurate, but depression and concentration problems have many causes. If a medication is already suppressing his testosterone, that medication may also have independent psychiatric effects. Treating the testosterone without examining the full picture is a valid starting point, but it is not the whole picture. His doctor presumably knows this. Viewers following along should.
He did not make any dosing recommendations to his audience, did not suggest anyone self-prescribe, and did not claim testosterone will cure anything. Credit where it is due.
What should you actually know?
A few things that did not come up in the video but matter if you are considering TRT yourself.
- Testosterone gels require consistent application and carry a real transfer risk to partners and children if skin contact happens before the gel dries. The FDA has flagged this repeatedly.
- Starting TRT can suppress your own natural testosterone production and affect fertility. For a 34-year-old, that conversation with a doctor is not optional.
- The "150s" floor he mentions is not a universal cutoff. Normal range varies by lab and by assay method. Total testosterone alone does not tell the whole story. Free testosterone and SHBG levels matter, especially when other medications are in the mix.
- If a medication is causing the suppression, there may be alternatives worth exploring before committing to long-term hormone replacement. That is a conversation for his prescriber, not TikTok.
- Vogelxo is a brand-name topical testosterone gel. It is not interchangeable with compounded testosterone gels, which are formulated differently and regulated under a separate framework.
Bottom line
This is one of the more responsible TRT debut videos you will find on the platform. The creator is transparent about his situation, references actual lab work, names a real prescribed medication, and is not pretending he has figured out the answers yet. The science behind his diagnosis holds up. The main gap is that attributing a cluster of symptoms entirely to one cause, before treatment has even started, is a hypothesis, not a conclusion. Follow-up videos will tell us more.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Brae👾 · TikTok creator
1.2K views on this video
My TRT Experience Day 0‼️ ##TRTJourney##TestosteroneTherapy##LowTRecovery##HormoneHealth#TRTResults
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about the endocrine society defines hypogonadism as total testosterone below 300?
The Endocrine Society defines hypogonadism as total testosterone below 300 ng/dL confirmed on two separate morning draws. Levels in the 70s ng/dL are severely deficient by any major guideline.
What does the video say about two morning testosterone tests before diagnosis?
Two morning testosterone tests before diagnosis is the correct clinical protocol per Bhasin et al., 2018, JCEM. Many people skip this step. The creator did not.
What does the video say about multiple medication classes, including opioids?
Multiple medication classes, including opioids and certain antidepressants, are documented causes of drug-induced secondary hypogonadism (Rajagopal et al., 2004, Journal of Pain and Symptom Management).
What does the video say about vogelxo?
Vogelxo is a brand-name testosterone gel regulated as an FDA-approved drug. It is not equivalent to compounded testosterone gels, which are prepared under a different regulatory framework.
What does the video say about testosterone gels carry an fda-documented transfer risk to partners?
Testosterone gels carry an FDA-documented transfer risk to partners and children if skin-to-skin contact occurs before the product fully dries.
What does the video say about trt in a 34-year-old man raises fertility considerations. exogenous testosterone?
TRT in a 34-year-old man raises fertility considerations. Exogenous testosterone suppresses LH and FSH, which can reduce sperm production. This warrants discussion with a urologist or reproductive endocrinologist before starting.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Brae👾, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.